OSF Cancer Institute is one of the chosen few participants in an exciting new cancer treatment trial program. The founder of ...

CIDRAP: Recombinant Pertussis Vaccine May Protect Teens For At Least 5 Years Researchers report that immunity against pertussis (whooping cough) was sustained 5 years after receipt of a ...

PhaseV, a pioneer in software and machine learning (ML) for advanced clinical trial optimization, announced today it will present at the AHLI Machine Learning for Health (ML4H) 2024 Symposium, taking ...

BOSTON and CAMBRIDGE, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics and ConcertAI announced the first phase of their Translational Oncology partnership, aligned around Dewpoint’s ...

The editor’s pick for this issue is a review article discussing the promise of hyperpolarised xenon MRI, a non-invasive ...

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...

Executives at a local company believe they have a quicker and less expensive path to get their new drug approved.

NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for Evidence-Based Psychiatry (CEBP) in Denmark has approved commencing enrollment of a clinical trial of ...

Almac Clinical Technologies is a global provider of Interactive Response Technology (IRT) and expert consultancy for the biopharmaceutical industry, empowering trial sponsors to pro-actively manage ...

Creating contingency plans against geopolitical uncertainty was a key theme at the 2024 Outsourcing in Clinical Trials and ...

A novel study from Korea uncovers the process of synthesis and pivotal role of the transfer RNA-derived fragment, ...

A new review published in Blood Cancer Discovery outlines a major multiple myeloma research project that supported a key ...